Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-69.13	7.37	23.86
Graham Fair Price	45.44	2264.84	1557.20
PEG	-24.41	0.04	0.06
Price/Book	-13.48	2.95	3.41
Price/Cash Flow	-40.91	5.85	9.90
Prices/Earnings	-36.21	3.10	4.85
Price/Sales	-5.85	1.40	1.49
Price/FCF	-40.91	5.85	9.90
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	154.58	0.26	0.10
Operating Margin	2736.32	0.18	< 0.005
ROA	83.99	0.03	0.02
ROE	0.18	0.24	35.64
ROIC	< 0.005	0.20	3327.44
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.05	-0.05	-1.36
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.93	32.41	3369.61
EPS QOQ	0.82	0.69	-15.61
FCF QOQ	-0.40	0.88	119.42
Revenue QOQ	0.04	0.18	341.53
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	6.16	7.25	17.74
Days Sales Outstanding (DSO)	17.29	13.37	-22.63
Inventory Turnover	14.61	12.41	-15.07
Debt/Capitalization	0.70	0.31	-56.26
Quick Ratio	0.86	1.00	16.14
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	783.49	978.44	24.88
Cash	1655.53	1888.56	14.08
Capex	-138.22	-25.02	81.90
Free Cash Flow	269.59	492.93	82.85
Revenue	1789.81	2054.01	14.76
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.98	1.13	16.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	5.98	1.47	-75.43
Naive Interpretation	Member

06 - Financial Health · Bad

Rating